Recursion Pharmaceuticals
Dave Hallett is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as Chief Scientific Officer at Recursion and previously at Exscientia. With a strong background in alliance management and chemistry as Executive Vice President at Evotec, Dave also held the position of Research Fellow at Merck. This extensive experience encompasses leadership roles in scientific development and strategic partnerships.
This person is not in any teams
This person is not in any offices
Recursion Pharmaceuticals
13 followers
Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.